TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effects of Post-Session Administration of D-cycloserine On Exposure Therapy Outcomes
Brief Summary: The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.


Options:
A: Arm Label: Cognitive Behavioral Group Therapy + D-Cycloserine; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Group Therapy (CBGT), Drug: D-Cycloserine | Arm Label: Cognitive Behavioral Group Therapy + Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Group Therapy (CBGT), Drug: Placebo | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Group Therapy (CBGT); Assigned to Arm(s): Cognitive Behavioral Group Therapy + D-Cycloserine, Cognitive Behavioral Group Therapy + Placebo | Intervention Type: DRUG; Name: D-Cycloserine; Assigned to Arm(s): Cognitive Behavioral Group Therapy + D-Cycloserine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Cognitive Behavioral Group Therapy + Placebo
B: Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: D-cycloserine; Assigned to Arm(s): N/A
C: Arm Label: Sugar Pill; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Individual Cognitive Behavioral Therapy (CBT), Drug: Placebo | Arm Label: D-Cycloserine; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Cognitive Behavioral Therapy (CBT), Drug: D-Cycloserine | Intervention Type: BEHAVIORAL; Name: Individual Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): D-Cycloserine, Sugar Pill | Intervention Type: DRUG; Name: D-Cycloserine; Assigned to Arm(s): D-Cycloserine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sugar Pill
D: Arm Label: D-cycloserine plus exposure therapy; Type: EXPERIMENTAL; Interventions: Drug: D-cycloserine, Behavioral: Exposure therapy | Arm Label: Placebo plus exposure therapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Exposure therapy, Drug: Placebo | Intervention Type: DRUG; Name: D-cycloserine; Assigned to Arm(s): D-cycloserine plus exposure therapy | Intervention Type: BEHAVIORAL; Name: Exposure therapy; Assigned to Arm(s): D-cycloserine plus exposure therapy, Placebo plus exposure therapy | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo plus exposure therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
Brief Summary: The purpose of the study is to evaluate the effect of an aerobic-resistance exercise program compared to a home based physical activity program on bone mass, body composition, metabolic risk factors and cardiovascular fitness in women with cancer who have completed therapy.


Options:
A: Arm Label: aerobic resistance; Type: EXPERIMENTAL; Interventions: Behavioral: aerobic resistance exercise | Arm Label: home based physical activity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: home based health promotion | Intervention Type: BEHAVIORAL; Name: aerobic resistance exercise; Assigned to Arm(s): aerobic resistance | Intervention Type: BEHAVIORAL; Name: home based health promotion; Assigned to Arm(s): home based physical activity
B: Arm Label: Arm I: Yoga Therapy; Type: EXPERIMENTAL; Interventions: Procedure: Yoga Therapy | Arm Label: Arm II: Wait-List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Yoga Therapy; Assigned to Arm(s): Arm I: Yoga Therapy
C: Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): N/A
D: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Attention Control (Health Education); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control (Health Education) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Attention Control (Health Education); Assigned to Arm(s): Attention Control (Health Education)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
Brief Summary: The purpose of the study is to evaluate the effect of an aerobic-resistance exercise program compared to a home based physical activity program on bone mass, body composition, metabolic risk factors and cardiovascular fitness in women with cancer who have completed therapy.


Options:
A: Arm Label: aerobic resistance; Type: EXPERIMENTAL; Interventions: Behavioral: aerobic resistance exercise | Arm Label: home based physical activity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: home based health promotion | Intervention Type: BEHAVIORAL; Name: aerobic resistance exercise; Assigned to Arm(s): aerobic resistance | Intervention Type: BEHAVIORAL; Name: home based health promotion; Assigned to Arm(s): home based physical activity
B: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Attention Control (Health Education); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control (Health Education) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Attention Control (Health Education); Assigned to Arm(s): Attention Control (Health Education)
C: Arm Label: Self-regulation plus activity monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Self-regulation plus activity monitoring | Arm Label: Self-regulation; Type: EXPERIMENTAL; Interventions: Behavioral: Self-regulation | Arm Label: Delayed intervention control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-regulation plus activity monitoring; Assigned to Arm(s): Self-regulation plus activity monitoring | Intervention Type: BEHAVIORAL; Name: Self-regulation; Assigned to Arm(s): Self-regulation
D: Arm Label: Intervention; Type: N/A; Interventions: Behavioral: educational/counseling intervention, Behavioral: therapeutic dietary intervention | Arm Label: Control; Type: N/A; Interventions: Behavioral: therapeutic dietary intervention | Intervention Type: BEHAVIORAL; Name: educational/counseling intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: therapeutic dietary intervention; Assigned to Arm(s): Control, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: SSRIs and Self-harm in Borderline Personality Disorder
Brief Summary: The goal of this study is to examine the effectiveness the selective serotonin reuptake inhibitor (SSRI) escitalopram (also known by the trade name "Lexapro") in reducing desire to self-harm and actual self-harming among young adults with borderline personality disorder who are also currently depressed. Subjects will receive either escitalopram or placebo for eight weeks. During this time subjects will be make weekly visits to see the psychiatrist and record their thoughts and feelings several times each day using an electronic diary.


Options:
A: Arm Label: Brexpiprazole 2-3 Milligrams Per Day; Type: EXPERIMENTAL; Interventions: Drug: Brexpiprazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Brexpiprazole; Assigned to Arm(s): Brexpiprazole 2-3 Milligrams Per Day | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Dialectical Behaviour Therapy-6 months; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy-6 months | Arm Label: Dialectical Behaviour Therapy-12 months; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dialectical Behaviour Therapy-12 months | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy-6 months; Assigned to Arm(s): Dialectical Behaviour Therapy-6 months | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy-12 months; Assigned to Arm(s): Dialectical Behaviour Therapy-12 months
C: Arm Label: Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Escitalopram | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram, Placebo
D: Arm Label: Presence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Presence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Absence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Absence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Absence of SUD with BCBT, Presence of SUD with BCBT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: SSRIs and Self-harm in Borderline Personality Disorder
Brief Summary: The goal of this study is to examine the effectiveness the selective serotonin reuptake inhibitor (SSRI) escitalopram (also known by the trade name "Lexapro") in reducing desire to self-harm and actual self-harming among young adults with borderline personality disorder who are also currently depressed. Subjects will receive either escitalopram or placebo for eight weeks. During this time subjects will be make weekly visits to see the psychiatrist and record their thoughts and feelings several times each day using an electronic diary.


Options:
A: Arm Label: Escitalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram | Arm Label: Duloxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Duloxetine | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): CBT
B: Arm Label: NMDA receptor antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: NMDA receptor antagonist (active drug) | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Other: Lactose packed capsule (inert/inactive arm) | Intervention Type: DRUG; Name: NMDA receptor antagonist (active drug); Assigned to Arm(s): NMDA receptor antagonist | Intervention Type: OTHER; Name: Lactose packed capsule (inert/inactive arm); Assigned to Arm(s): Placebo tablet
C: Arm Label: Zero Suicide Quality Improvement (ZSQI); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Zero Suicide Quality Improvement | Arm Label: Stepped Care for Suicide Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Stepped Care for Suicide Prevention, Behavioral: Zero Suicide Quality Improvement | Intervention Type: BEHAVIORAL; Name: Stepped Care for Suicide Prevention; Assigned to Arm(s): Stepped Care for Suicide Prevention | Intervention Type: BEHAVIORAL; Name: Zero Suicide Quality Improvement; Assigned to Arm(s): Stepped Care for Suicide Prevention, Zero Suicide Quality Improvement (ZSQI)
D: Arm Label: Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Escitalopram | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram, Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutrition, Growth and Development Among Very Preterm Infants
Brief Summary: The main purpose of this study is to evaluate the effect of increased supply of energy, protein, vitamin A and the long chain polyunsaturated fatty acids docosahexaenoic acid and arachidonic acid on growth, brain maturation and cognitive function.


Options:
A: Arm Label: Standard Protein Group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard fortification | Arm Label: Enhanced Protein Group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein supplementation, Dietary Supplement: Standard fortification | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein supplementation; Assigned to Arm(s): Enhanced Protein Group | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard fortification; Assigned to Arm(s): Enhanced Protein Group, Standard Protein Group
B: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nutrition | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Nutrition | Intervention Type: DIETARY_SUPPLEMENT; Name: Nutrition; Assigned to Arm(s): Control, Intervention
C: Arm Label: Intervention group; Type: OTHER; Interventions: Dietary Supplement: Addition of human milk fortifiers according to human milk analysis | Intervention Type: DIETARY_SUPPLEMENT; Name: Addition of human milk fortifiers according to human milk analysis; Assigned to Arm(s): Intervention group
D: Arm Label: Individualized fortification of breast milk; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Individualized fortification of breast milk | Arm Label: Routine fortification of breast milk; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Routine fortification of breast milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Individualized fortification of breast milk; Assigned to Arm(s): Individualized fortification of breast milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Routine fortification of breast milk; Assigned to Arm(s): Routine fortification of breast milk

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutrition, Growth and Development Among Very Preterm Infants
Brief Summary: The main purpose of this study is to evaluate the effect of increased supply of energy, protein, vitamin A and the long chain polyunsaturated fatty acids docosahexaenoic acid and arachidonic acid on growth, brain maturation and cognitive function.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: MicroLipid and fish oil | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine care | Intervention Type: DIETARY_SUPPLEMENT; Name: MicroLipid and fish oil; Assigned to Arm(s): Treatment | Intervention Type: OTHER; Name: Routine care; Assigned to Arm(s): Control Group
B: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nutrition | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Nutrition | Intervention Type: DIETARY_SUPPLEMENT; Name: Nutrition; Assigned to Arm(s): Control, Intervention
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Docosahexaenoic acid (DHA) | Intervention Type: DIETARY_SUPPLEMENT; Name: Docosahexaenoic acid (DHA); Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 4; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: DHA and ARA; Assigned to Arm(s): 1, 2, 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 4

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: FOAM-study Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins: a Randomized Controlled Study
Brief Summary: Varicose vein disease is a common health problem, which causes much discomfort to patients.

Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided foam sclerotherapy. These are two equally accepted and applied treatments for the same patient population.

Choice of treatment often depends on the referral preference of the General Practitioner. Until now data are missing which treatment is more cost effective. The current proposal aims at comparing the effects, costs and patient preferences between duplex guided foam sclerotherapy and surgery in the treatment of greater varicose veins.


Options:
A: Arm Label: Operative treatment; Type: OTHER; Interventions: Procedure: Operative treatment | Arm Label: Laser ablation; Type: OTHER; Interventions: Procedure: Laser ablation | Arm Label: Foam sclerotherapy; Type: OTHER; Interventions: Procedure: Foam sclerotherapy | Intervention Type: PROCEDURE; Name: Operative treatment; Assigned to Arm(s): Operative treatment | Intervention Type: PROCEDURE; Name: Laser ablation; Assigned to Arm(s): Laser ablation | Intervention Type: PROCEDURE; Name: Foam sclerotherapy; Assigned to Arm(s): Foam sclerotherapy
B: Arm Label: Conventional Surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Surgery | Arm Label: Radiofrequency Ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radiofrequency Ablation | Intervention Type: PROCEDURE; Name: Conventional Surgery; Assigned to Arm(s): Conventional Surgery | Intervention Type: PROCEDURE; Name: Radiofrequency Ablation; Assigned to Arm(s): Radiofrequency Ablation
C: Arm Label: RFA; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radiofrequency ablation (RFA) | Arm Label: MOCA; Type: EXPERIMENTAL; Interventions: Device: Mechanochemical Endovenous Ablation (MOCA) | Intervention Type: DEVICE; Name: Mechanochemical Endovenous Ablation (MOCA); Assigned to Arm(s): MOCA | Intervention Type: PROCEDURE; Name: Radiofrequency ablation (RFA); Assigned to Arm(s): RFA
D: Arm Label: high ligation and stripping; Type: ACTIVE_COMPARATOR; Interventions: Procedure: high ligation and stripping (surgery) | Arm Label: duplex guided foam sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: FOAM | Intervention Type: PROCEDURE; Name: high ligation and stripping (surgery); Assigned to Arm(s): high ligation and stripping | Intervention Type: PROCEDURE; Name: FOAM; Assigned to Arm(s): duplex guided foam sclerotherapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Phase III Study of Regorafenib Plus BSC Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Brief Summary: This is a randomized, double-blind, placebo-controlled multi-center phase III study to evaluate efficacy and safety of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed on/after all approved drugs for CRC


Options:
A: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: AMG 386 Placebo, Drug: FOLFIRI | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: AMG 386, Drug: FOLFIRI | Intervention Type: DRUG; Name: AMG 386; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: AMG 386 Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: FOLFIRI; Assigned to Arm(s): 1, 2
B: Arm Label: Regorafenib (Stivarga, BAY73-4506)+BSC; Type: EXPERIMENTAL; Interventions: Drug: Regorafenib (Stivarga, BAY73-4506), Other: Best Supportive Care (BSC) | Arm Label: Placebo+BSC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Regorafenib (Stivarga, BAY73-4506); Assigned to Arm(s): Regorafenib (Stivarga, BAY73-4506)+BSC | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo+BSC | Intervention Type: OTHER; Name: Best Supportive Care (BSC); Assigned to Arm(s): Placebo+BSC, Regorafenib (Stivarga, BAY73-4506)+BSC
C: Intervention Type: DRUG; Name: 5-fluorouracil; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: leucovorin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: irinotecan; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: oxaliplatin; Assigned to Arm(s): N/A
D: Intervention Type: BIOLOGICAL; Name: cetuximab; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Distress on the IVF Outcome
Brief Summary: Stress is a primary reason why in vitro fertilization (IVF) patients drop out of treatment, and it may have a detrimental impact on pregnancy rates, yet there is minimal published research on the efficacy of structured skills-based psychological interventions with assisted reproductive technology (ART) patients. The objective of this study is to determine if women who are randomized to a mind/body (MB) program prior to starting their first IVF cycle will have higher pregnancy rates than controls (C).

This is a randomized, controlled prospective study conducted at a private academically-affiliated infertility clinic and includes 143 women ages 40 and below scheduled to undergo their first IVF cycle. Subjects are randomized via computer generated random numbers table to a 10 session mind/body program or a control group and followed for two IVF cycles. The primary outcome measure is clinical pregnancy rate.


Options:
A: Arm Label: Control (Spa Certificate); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Arm Label: Mind/Body Program; Type: EXPERIMENTAL; Interventions: Behavioral: Mind/Body Program | Intervention Type: BEHAVIORAL; Name: Mind/Body Program; Assigned to Arm(s): Mind/Body Program | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control (Spa Certificate)
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Arm Label: Intensive Dietary Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Intensive Dietary Intervention; Assigned to Arm(s): Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: PreLiFe-programme; Type: EXPERIMENTAL; Interventions: Behavioral: PreLiFe-programme, Behavioral: Attention Control Programme | Arm Label: Attention Control; Type: OTHER; Interventions: Behavioral: Attention Control Programme | Intervention Type: BEHAVIORAL; Name: PreLiFe-programme; Assigned to Arm(s): PreLiFe-programme | Intervention Type: BEHAVIORAL; Name: Attention Control Programme; Assigned to Arm(s): Attention Control, PreLiFe-programme
D: Arm Label: IVF only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Weight reduction treatment and IVF; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Low calorie diet treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Low calorie diet treatment; Assigned to Arm(s): Weight reduction treatment and IVF

Answer: A